[8-K] Biogen Inc. Reports Material Event
Biogen held its 2025 Annual Meeting of Stockholders on June 17, 2025, with three key matters put to vote. All eleven nominated directors were successfully elected to serve one-year terms until the 2026 annual meeting, with notable strong support for Lloyd Minor, Menelas Pangalos, and Monish Patolawala, each receiving over 114 million votes in favor.
Key voting outcomes include:
- Independent Auditor Appointment: PricewaterhouseCoopers LLP was ratified as the independent auditor for FY2025 with strong support (120,065,433 votes in favor)
- Say-on-Pay Vote: The executive compensation package was approved, though with more divided support - 78.5 million votes in favor versus 37.1 million against
The relatively split vote on executive compensation (67.8% approval) suggests some shareholder concerns about leadership remuneration. The high broker non-votes (10.2 million) across most items indicate significant holdings by institutional investors who did not provide voting instructions.
Biogen ha tenuto la sua Assemblea Annuale degli Azionisti 2025 il 17 giugno 2025, con tre questioni principali poste al voto. Tutti gli undici direttori nominati sono stati eletti con successo per un mandato di un anno fino all'assemblea del 2026, con un sostegno particolarmente forte per Lloyd Minor, Menelas Pangalos e Monish Patolawala, ognuno dei quali ha ricevuto oltre 114 milioni di voti favorevoli.
I risultati chiave delle votazioni includono:
- Nomina del Revisore Indipendente: PricewaterhouseCoopers LLP 猫 stata confermata come revisore indipendente per l'esercizio 2025 con un forte sostegno (120.065.433 voti a favore)
- Voto Say-on-Pay: Il pacchetto di compensi esecutivi 猫 stato approvato, sebbene con un sostegno pi霉 diviso - 78,5 milioni di voti a favore contro 37,1 milioni contrari
Il voto relativamente diviso sulla retribuzione esecutiva (67,8% di approvazione) suggerisce alcune preoccupazioni degli azionisti riguardo alla remunerazione della leadership. L'alto numero di broker non-votanti (10,2 milioni) nella maggior parte delle votazioni indica una significativa presenza di investitori istituzionali che non hanno fornito istruzioni di voto.
Biogen celebr贸 su Junta Anual de Accionistas 2025 el 17 de junio de 2025, con tres asuntos clave sometidos a votaci贸n. Los once directores nominados fueron elegidos con 茅xito para mandatos de un a帽o hasta la junta de 2026, con un apoyo notable para Lloyd Minor, Menelas Pangalos y Monish Patolawala, cada uno recibiendo m谩s de 114 millones de votos a favor.
Los resultados clave de la votaci贸n incluyen:
- Nombramiento del Auditor Independiente: PricewaterhouseCoopers LLP fue ratificado como auditor independiente para el a帽o fiscal 2025 con un fuerte respaldo (120,065,433 votos a favor)
- Voto Say-on-Pay: El paquete de compensaci贸n ejecutiva fue aprobado, aunque con un apoyo m谩s dividido - 78.5 millones de votos a favor frente a 37.1 millones en contra
El voto relativamente dividido sobre la compensaci贸n ejecutiva (67.8% de aprobaci贸n) sugiere algunas preocupaciones de los accionistas sobre la remuneraci贸n del liderazgo. El alto n煤mero de votos en blanco por parte de los brokers (10.2 millones) en la mayor铆a de los puntos indica una significativa participaci贸n de inversores institucionales que no proporcionaron instrucciones de voto.
Biogen鞚� 2025雲� 6鞗� 17鞚� 2025雲� 鞐半 欤检＜齑濏殞毳� 臧滌禍頄堨溂氅�, 靹� 臧�歆� 欤检殧 鞎堦贝鞐� 雽�頃� 韴憸毳� 歆勴枆頄堨姷雼堧嫟. 歆�氇呺悳 11氇呾潣 鞚挫偓 鞝勳洂鞚� 靹标车鞝侅溂搿� 靹犾稖霅橃柎 2026雲� 鞐半 齑濏殞旯岇 1雲� 鞛勱赴毳� 毵￡矊 霅橃棃鞙茧┌, Lloyd Minor, Menelas Pangalos, Monish Patolawala電� 臧侁皝 1鞏� 1,400毵� 響� 鞚挫儊鞚� 臧曤牓頃� 歆�歆�毳� 氚涭晿鞀惦媹雼�.
欤检殧 韴憸 瓴瓣臣電� 雼れ潓瓿� 臧欖姷雼堧嫟:
- 霃呺 臧愳偓鞚� 靹犾瀯: PricewaterhouseCoopers LLP臧� 2025 須岅硠鞐半弰 霃呺 臧愳偓鞚胳溂搿� 臧曤牓頃� 歆�歆�(1鞏� 2,006毵� 5,433響� 彀劚)毳� 氚涭晞 鞀轨澑霅橃棃鞀惦媹雼�.
- 鞛勳洂 氤挫垬鞐� 雽�頃� 彀皹 韴憸(Say-on-Pay): 瓴届榿歆� 氤挫垬 韺偆歆�電� 彀皹鞚� 雮橂墭鞐堨溂雮� 鞀轨澑霅橃棃鞙茧┌, 彀劚 7,850毵� 響�, 氚橂寑 3,710毵� 響滌榾鞀惦媹雼�.
鞛勳洂 氤挫垬鞐� 雽�頃� 牍勱祼鞝� 攵勳棿霅� 韴憸 瓴瓣臣(67.8% 鞀轨澑)電� 瓴届榿歆� 氤挫儊鞐� 雽�頃� 鞚茧秬 欤检＜鞚� 鞖半牑毳� 氚橃榿頃╇媹雼�. 雽�攵�攵� 鞎堦贝鞐愳劀 欷戧皽鞚� 氍错埇響�(1,020毵� 響�)鞚� 雴掛潃 牍勳湪鞚� 韴憸 歆�鞁滊ゼ 鞝滉车頃橃 鞎婌潃 旮瓣磤 韴瀽鞛愳潣 靸侂嫻頃� 歆�攵勳潉 雮橅儉雰呺媹雼�.
Biogen a tenu son Assembl茅e G茅n茅rale Annuelle des Actionnaires 2025 le 17 juin 2025, avec trois points cl茅s soumis au vote. Tous les onze administrateurs propos茅s ont 茅t茅 茅lus avec succ猫s pour un mandat d'un an jusqu'脿 l'assembl茅e de 2026, avec un soutien particuli猫rement fort pour Lloyd Minor, Menelas Pangalos et Monish Patolawala, chacun recevant plus de 114 millions de votes favorables.
Les r茅sultats cl茅s des votes incluent :
- Nomination de l'auditeur ind茅pendant : PricewaterhouseCoopers LLP a 茅t茅 ratifi茅 en tant qu'auditeur ind茅pendant pour l'exercice 2025 avec un fort soutien (120 065 433 votes en faveur)
- Vote Say-on-Pay : Le paquet de r茅mun茅ration des dirigeants a 茅t茅 approuv茅, bien que le soutien ait 茅t茅 plus partag茅 - 78,5 millions de votes pour contre 37,1 millions contre
Le vote relativement partag茅 sur la r茅mun茅ration des dirigeants (67,8 % d'approbation) sugg猫re certaines pr茅occupations des actionnaires concernant la r茅mun茅ration de la direction. Le nombre 茅lev茅 de votes non exprim茅s par les courtiers (10,2 millions) sur la plupart des points indique une participation importante d'investisseurs institutionnels n'ayant pas donn茅 d'instructions de vote.
Biogen hielt am 17. Juni 2025 seine Jahreshauptversammlung 2025 ab, bei der drei wichtige Punkte zur Abstimmung standen. Alle elf vorgeschlagenen Direktoren wurden erfolgreich gew盲hlt, um einj盲hrige Amtszeiten bis zur Hauptversammlung 2026 zu 眉bernehmen, wobei Lloyd Minor, Menelas Pangalos und Monish Patolawala mit jeweils 眉ber 114 Millionen Stimmen besonders starke Unterst眉tzung erhielten.
Wichtige Abstimmungsergebnisse sind:
- Best盲tigung des unabh盲ngigen Wirtschaftspr眉fers: PricewaterhouseCoopers LLP wurde als unabh盲ngiger Pr眉fer f眉r das Gesch盲ftsjahr 2025 mit gro脽er Mehrheit best盲tigt (120.065.433 Stimmen daf眉r)
- Say-on-Pay-Abstimmung: Das Verg眉tungspaket f眉r F眉hrungskr盲fte wurde genehmigt, allerdings mit geteilter Zustimmung 鈥� 78,5 Millionen Stimmen daf眉r gegen眉ber 37,1 Millionen dagegen
Die relativ geteilte Zustimmung zur Vorstandsverg眉tung (67,8 % Zustimmung) deutet auf einige Bedenken der Aktion盲re hinsichtlich der F眉hrungskr盲fteverg眉tung hin. Die hohe Anzahl von Broker-Non-Votes (10,2 Millionen) bei den meisten Punkten zeigt, dass bedeutende institutionelle Investoren keine Abstimmungsanweisungen erteilt haben.
- Strong board election results for key scientific leaders: Dr. Minor and Dr. Pangalos received overwhelming approval with ~99% of votes in favor
- Strong shareholder support (95.7%) for PricewaterhouseCoopers LLP as independent auditor indicates confidence in financial oversight
- Significant opposition to executive compensation package with 32% (37.1M shares) voting against the advisory pay proposal, indicating substantial shareholder dissatisfaction with compensation practices
- Notable opposition to several board members with Caroline D. Dorsa, Jesus B. Mantas, and Eric K. Rowinsky each receiving over 20% votes against their election, suggesting governance concerns
Insights
Biogen's say-on-pay vote received only 68% support, signaling significant shareholder dissatisfaction with executive compensation practices.
The voting results from Biogen's annual meeting reveal concerning governance signals that merit investor attention. Most notably, the advisory vote on executive compensation passed with only 68% support (78.5M votes for vs. 37.1M against), indicating substantial shareholder dissatisfaction. In corporate governance standards, say-on-pay approval below 70% is considered a red flag that typically triggers additional board engagement with institutional investors.
Several director elections also show meaningful opposition. Five directors received over 19.6M votes against their election, with Caroline Dorsa and Eric Rowinsky facing particularly strong opposition (25.4M and 24.7M votes against, respectively). This voting pattern suggests fragmented shareholder confidence in board oversight. In contrast, three directors (Minor, Pangalos, and Patolawala) received overwhelming support with over 114M votes in favor and minimal opposition.
The split voting patterns indicate shareholders are making thoughtful distinctions between individual directors rather than voting along a straight ticket, demonstrating active engagement in Biogen's governance. This level of targeted opposition often precedes more aggressive shareholder activism, particularly given the mediocre support for executive compensation. The board would be prudent to address these governance concerns proactively before the next proxy season.
Biogen ha tenuto la sua Assemblea Annuale degli Azionisti 2025 il 17 giugno 2025, con tre questioni principali poste al voto. Tutti gli undici direttori nominati sono stati eletti con successo per un mandato di un anno fino all'assemblea del 2026, con un sostegno particolarmente forte per Lloyd Minor, Menelas Pangalos e Monish Patolawala, ognuno dei quali ha ricevuto oltre 114 milioni di voti favorevoli.
I risultati chiave delle votazioni includono:
- Nomina del Revisore Indipendente: PricewaterhouseCoopers LLP 猫 stata confermata come revisore indipendente per l'esercizio 2025 con un forte sostegno (120.065.433 voti a favore)
- Voto Say-on-Pay: Il pacchetto di compensi esecutivi 猫 stato approvato, sebbene con un sostegno pi霉 diviso - 78,5 milioni di voti a favore contro 37,1 milioni contrari
Il voto relativamente diviso sulla retribuzione esecutiva (67,8% di approvazione) suggerisce alcune preoccupazioni degli azionisti riguardo alla remunerazione della leadership. L'alto numero di broker non-votanti (10,2 milioni) nella maggior parte delle votazioni indica una significativa presenza di investitori istituzionali che non hanno fornito istruzioni di voto.
Biogen celebr贸 su Junta Anual de Accionistas 2025 el 17 de junio de 2025, con tres asuntos clave sometidos a votaci贸n. Los once directores nominados fueron elegidos con 茅xito para mandatos de un a帽o hasta la junta de 2026, con un apoyo notable para Lloyd Minor, Menelas Pangalos y Monish Patolawala, cada uno recibiendo m谩s de 114 millones de votos a favor.
Los resultados clave de la votaci贸n incluyen:
- Nombramiento del Auditor Independiente: PricewaterhouseCoopers LLP fue ratificado como auditor independiente para el a帽o fiscal 2025 con un fuerte respaldo (120,065,433 votos a favor)
- Voto Say-on-Pay: El paquete de compensaci贸n ejecutiva fue aprobado, aunque con un apoyo m谩s dividido - 78.5 millones de votos a favor frente a 37.1 millones en contra
El voto relativamente dividido sobre la compensaci贸n ejecutiva (67.8% de aprobaci贸n) sugiere algunas preocupaciones de los accionistas sobre la remuneraci贸n del liderazgo. El alto n煤mero de votos en blanco por parte de los brokers (10.2 millones) en la mayor铆a de los puntos indica una significativa participaci贸n de inversores institucionales que no proporcionaron instrucciones de voto.
Biogen鞚� 2025雲� 6鞗� 17鞚� 2025雲� 鞐半 欤检＜齑濏殞毳� 臧滌禍頄堨溂氅�, 靹� 臧�歆� 欤检殧 鞎堦贝鞐� 雽�頃� 韴憸毳� 歆勴枆頄堨姷雼堧嫟. 歆�氇呺悳 11氇呾潣 鞚挫偓 鞝勳洂鞚� 靹标车鞝侅溂搿� 靹犾稖霅橃柎 2026雲� 鞐半 齑濏殞旯岇 1雲� 鞛勱赴毳� 毵￡矊 霅橃棃鞙茧┌, Lloyd Minor, Menelas Pangalos, Monish Patolawala電� 臧侁皝 1鞏� 1,400毵� 響� 鞚挫儊鞚� 臧曤牓頃� 歆�歆�毳� 氚涭晿鞀惦媹雼�.
欤检殧 韴憸 瓴瓣臣電� 雼れ潓瓿� 臧欖姷雼堧嫟:
- 霃呺 臧愳偓鞚� 靹犾瀯: PricewaterhouseCoopers LLP臧� 2025 須岅硠鞐半弰 霃呺 臧愳偓鞚胳溂搿� 臧曤牓頃� 歆�歆�(1鞏� 2,006毵� 5,433響� 彀劚)毳� 氚涭晞 鞀轨澑霅橃棃鞀惦媹雼�.
- 鞛勳洂 氤挫垬鞐� 雽�頃� 彀皹 韴憸(Say-on-Pay): 瓴届榿歆� 氤挫垬 韺偆歆�電� 彀皹鞚� 雮橂墭鞐堨溂雮� 鞀轨澑霅橃棃鞙茧┌, 彀劚 7,850毵� 響�, 氚橂寑 3,710毵� 響滌榾鞀惦媹雼�.
鞛勳洂 氤挫垬鞐� 雽�頃� 牍勱祼鞝� 攵勳棿霅� 韴憸 瓴瓣臣(67.8% 鞀轨澑)電� 瓴届榿歆� 氤挫儊鞐� 雽�頃� 鞚茧秬 欤检＜鞚� 鞖半牑毳� 氚橃榿頃╇媹雼�. 雽�攵�攵� 鞎堦贝鞐愳劀 欷戧皽鞚� 氍错埇響�(1,020毵� 響�)鞚� 雴掛潃 牍勳湪鞚� 韴憸 歆�鞁滊ゼ 鞝滉车頃橃 鞎婌潃 旮瓣磤 韴瀽鞛愳潣 靸侂嫻頃� 歆�攵勳潉 雮橅儉雰呺媹雼�.
Biogen a tenu son Assembl茅e G茅n茅rale Annuelle des Actionnaires 2025 le 17 juin 2025, avec trois points cl茅s soumis au vote. Tous les onze administrateurs propos茅s ont 茅t茅 茅lus avec succ猫s pour un mandat d'un an jusqu'脿 l'assembl茅e de 2026, avec un soutien particuli猫rement fort pour Lloyd Minor, Menelas Pangalos et Monish Patolawala, chacun recevant plus de 114 millions de votes favorables.
Les r茅sultats cl茅s des votes incluent :
- Nomination de l'auditeur ind茅pendant : PricewaterhouseCoopers LLP a 茅t茅 ratifi茅 en tant qu'auditeur ind茅pendant pour l'exercice 2025 avec un fort soutien (120 065 433 votes en faveur)
- Vote Say-on-Pay : Le paquet de r茅mun茅ration des dirigeants a 茅t茅 approuv茅, bien que le soutien ait 茅t茅 plus partag茅 - 78,5 millions de votes pour contre 37,1 millions contre
Le vote relativement partag茅 sur la r茅mun茅ration des dirigeants (67,8 % d'approbation) sugg猫re certaines pr茅occupations des actionnaires concernant la r茅mun茅ration de la direction. Le nombre 茅lev茅 de votes non exprim茅s par les courtiers (10,2 millions) sur la plupart des points indique une participation importante d'investisseurs institutionnels n'ayant pas donn茅 d'instructions de vote.
Biogen hielt am 17. Juni 2025 seine Jahreshauptversammlung 2025 ab, bei der drei wichtige Punkte zur Abstimmung standen. Alle elf vorgeschlagenen Direktoren wurden erfolgreich gew盲hlt, um einj盲hrige Amtszeiten bis zur Hauptversammlung 2026 zu 眉bernehmen, wobei Lloyd Minor, Menelas Pangalos und Monish Patolawala mit jeweils 眉ber 114 Millionen Stimmen besonders starke Unterst眉tzung erhielten.
Wichtige Abstimmungsergebnisse sind:
- Best盲tigung des unabh盲ngigen Wirtschaftspr眉fers: PricewaterhouseCoopers LLP wurde als unabh盲ngiger Pr眉fer f眉r das Gesch盲ftsjahr 2025 mit gro脽er Mehrheit best盲tigt (120.065.433 Stimmen daf眉r)
- Say-on-Pay-Abstimmung: Das Verg眉tungspaket f眉r F眉hrungskr盲fte wurde genehmigt, allerdings mit geteilter Zustimmung 鈥� 78,5 Millionen Stimmen daf眉r gegen眉ber 37,1 Millionen dagegen
Die relativ geteilte Zustimmung zur Vorstandsverg眉tung (67,8 % Zustimmung) deutet auf einige Bedenken der Aktion盲re hinsichtlich der F眉hrungskr盲fteverg眉tung hin. Die hohe Anzahl von Broker-Non-Votes (10,2 Millionen) bei den meisten Punkten zeigt, dass bedeutende institutionelle Investoren keine Abstimmungsanweisungen erteilt haben.
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
| Nominee | Votes For | Votes Against | Abstentions | Broker Non-Votes | ||||||||||||||||||||||
| Caroline D. Dorsa | 90,200,723 | 25,487,099 | 321,364 | 10,206,851 | ||||||||||||||||||||||
| Maria C. Freire | 96,061,538 | 19,660,536 | 287,112 | 10,206,851 | ||||||||||||||||||||||
| William A. Hawkins | 96,010,449 | 19,771,738 | 226,999 | 10,206,851 | ||||||||||||||||||||||
| Susan K. Langer | 96,160,359 | 19,623,542 | 225,285 | 10,206,851 | ||||||||||||||||||||||
| Jesus B. Mantas | 93,427,720 | 22,348,175 | 233,291 | 10,206,851 | ||||||||||||||||||||||
| Lloyd Minor | 114,975,935 | 692,399 | 340,852 | 10,206,851 | ||||||||||||||||||||||
| Menelas Pangalos | 114,986,403 | 695,239 | 327,544 | 10,206,851 | ||||||||||||||||||||||
| Monish Patolawala | 115,162,666 | 520,650 | 325,870 | 10,206,851 | ||||||||||||||||||||||
| Eric K. Rowinsky | 91,034,039 | 24,745,219 | 229,928 | 10,206,851 | ||||||||||||||||||||||
| Stephen A. Sherwin | 95,785,706 | 19,996,175 | 227,305 | 10,206,851 | ||||||||||||||||||||||
| Christopher A. Viehbacher | 114,893,329 | 883,866 | 231,991 | 10,206,851 | ||||||||||||||||||||||
| Votes For | Votes Against | Abstentions | Broker Non-Votes | |||||||||||||||||
| 120,065,433 | 5,916,416 | 234,188 | — | |||||||||||||||||
| Votes For | Votes Against | Abstentions | Broker Non-Votes | |||||||||||||||||
| 78,531,756 | 37,113,368 | 364,062 | 10,206,851 | |||||||||||||||||
Exhibit No. | Description | |||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
Source:
FAQ
What were the voting results for BIIB's CEO Christopher Viehbacher at the 2025 Annual Meeting?
Did BIIB shareholders approve the 2025 executive compensation package?
Who was appointed as BIIB's independent auditor for fiscal year 2025?
How many directors were elected to BIIB's board at the 2025 Annual Meeting?
Which BIIB board member received the highest shareholder approval at the 2025 Annual Meeting?
